Deep Brain Stimulation Devices Market Size, Share & Trends Report

Deep Brain Stimulation Devices Market Size, Share & Trends Analysis Report By Application (Pain Management, Epilepsy, Essential Tremor, OCD, Depression, Dystonia, Parkinson’s), By Region, And Segment Forecasts, 2018 - 2025

  • Published Date: May, 2018
  • Base Year for Estimate: 2016
  • Report ID: 978-1-68038-335-5
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 69

Industry Outlook

The global deep brain stimulation devices market size was valued at USD 795.64 million in 2016. It is expected to experience a CAGR of 11.5% over the forecast period. Increasing prevalence of neurological diseases, such as Parkinson’s disease, epilepsy, essential tremor, and dystonia, is one of the key trends promoting market growth. 

U.S. deep brain stimulation devices market

Prevalence of stress and obesity-induced depression across the globe is constantly increasing. According to the National Institute of Mental Health (NIHM), in 2012, 16.0 million adults had been through at least one major depressive episode in the U.S. In addition, as per WHO, more than 300.0 million adults worldwide are suffering from depression.

High mortality and disease burden create clinical urgency for incorporation of long-term solutions such as deep brain stimulators. The product been proved to play an important role in providing therapeutic solutions for depression, therefore a rise in the prevalence of such diseases is anticipated to present immense growth prospects during the forecast period.

Technological advancements in deep brain stimulators are estimated to shape growth of the market. These advancements include enhanced microelectrode designs, robot-assisted implantation, multi-target stimulation, integrated implantable pulse generators, individualized directed programming, and MRI. Due to these advancements in recent times, deep brain stimulators have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with movement disorders as compared to conventional methods.

In addition, potential benefits of deep brain stimulation therapy, such as better management of postoperative outcomes and long-term efficacy, are projected to facilitate growth over the forecast period. Furthermore, these advancements aid clinical researchers and physicians in investigational efficacy studies for usage of DBS in off-label clinical applications such as depression.

Application Insights

Parkinson's disease is a common neurodegenerative disorder with fewer treatment alternatives. In 2016, Parkinson's disease held the largest share in the market due to increase in the number of U.S. FDA approvals for DBS therapies that can be used in the treatment of the disease. Increasing prevalence of the disease is the primary factor contributing to the growth of the segment.

Long-term costs associated with medications for Parkinson’s disease is leading to an increase in adoption of DBS, thus resulting in a greater market share. According to the International Journal of Neurology and Neurotherapy, medication usage reduced by approximately 25% to 50% within 6 months of DBS placement in patients.

Epilepsy is likely to witness remarkable CAGR during the forecast period. DBS is used in epilepsy due to lower therapeutic response to medication in seizures and lower success rates associated with surgeries. Clinical studies such as Stimulation of Anterior Nucleus of Thalamus for Epilepsy (SANTE), conducted by Medtronic in 2012, demonstrated 69.0% reduction in seizure frequency.

Regional Insights

North America dominated the DBS market in 2016 owing to rising prevalence of movement and psychiatric disorders coupled with increasing geriatric population in the region. According to the Parkinson's Disease Foundation (PDF), symptoms of Parkinson's disease are common at an average age of 60. Increasing government funding and initiatives for raising awareness about movement disorders are poised to fuel the demand for deep brain stimulators in the region.

Global deep brain stimulation devices market

Asia Pacific is expected to be the most promising destination for DBS manufacturers during the forecast period. Rising prevalence of neurodegenerative and psychiatric disorders coupled with high unmet demand for effective and long-term treatment solutions is anticipated to supplement the growth of the regional market. Growing preference for clinical trials and high R&D investments by global players owing to availability of low cost labor in the region will also rev up the rate of adoption of seep brain stimulators in the region. 

Deep Brain Stimulators (DBS) Market Share Insights

The market is highly competitive and consolidated in nature. The leading companies operating in the market are St. Jude Medical, Inc.; Boston Scientific Corporation; and Medtronic PLC, Inc.

The key companies are highly inclined towards improving overall health outcomes. In addition, they are consistently striving to achieve profit margins through regional expansion. Moreover, greater focus on strengthening distribution and refinement of operation structures are helping market players consolidate their position in the market.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2014 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Report coverage      

Revenue forecast, company share, competitive landscape, growth factors and trends

Country Scope

U.S., Canada, U.K., Germany, Japan, Brazil

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global deep brain stimulators market report on the basis of application and region:

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Pain Management

    • Epilepsy

    • Essential tumor

    • Obsessive Compulsive Disorder (OCD)

    • Depression

    • Dystonia

    • Parkinson’s

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

    • Asia Pacific

      • Japan

    • RoW

      • Brazil

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Compass Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified